Deadline: Ongoing
Applications are open for the MSWA Multiple Sclerosis & Neurological Care Accelerator 2026. MSWA and Founders Factory have partnered to fast-track global startups developing innovations that transform care for people living with MS and other neurological conditions.
The program supports early-stage ventures harnessing AI, robotics, wearables, and digital health to address multiple sclerosis, stroke, Parkinson’s disease, Huntington’s disease, motor neurone disease and acquired brain injury. Founders gain access to investment, expert-led workshops, 1:1 mentoring, and access to a global network of clinicians, researchers, and health tech leaders. Together, our goal is to turn breakthrough ideas into tangible improvements in care, mobility, and independence.
Designed and delivered by MSWA and Founders Factory, the program strengthens Western Australia’s growing innovation ecosystem and advances MSWA’s mission to help people with neurological conditions experience a better quality of life.
Focus Areas
They are supporting startups innovating in MS Tech and neurological care:
- AI-Driven Healthcare Transformation
- New Research & Healthcare Solutions for First Nation Communities
- Next-Generation Vaccines & Advanced Scientific Breakthroughs
- Robotics & Mobility Enhancement
- Frontier Innovations
Benefits
- Capital: Receive cash investment and opportunities for follow-on funding through their investor networks.
- Operational Excellence: Four months of expert-led programming across product development, operations, commercialisation, data science, partnerships, and fundraising.
- Industry Access: Commercial opportunities with MSWA and a global network of healthcare organisations and clinicians.
- Venture Ecosystem: Connect with a global community of founders, operators and investors at private in-person and online events.
- Playbooks & Resources: Leverage the venture building knowledge, systems and processes to de-risk your startup and increase the probabilities of success.
- Deals & Perks: Access hand-picked deals, discounts and benefits with leading software and service providers, worth AU$500,000.
Eligibility
- Open to early-stage ventures harnessing AI, robotics, wearables, and digital health to address multiple sclerosis, stroke, Parkinson’s disease, Huntington’s disease, motor neurone disease and acquired brain injury.
- Ventures should be based in Australia.
Application
For more information, visit MSWA Multiple Sclerosis & Neurological Care Accelerator.
